Bayer Receives FDA Endorsement to Accelerate Development of Parkinson Treatment
Bayer's subsidiary AskBio received approval from the U.S. drug regulator to accelerate the development of its investigational gene therapy to treat moderate-stage Parkinson's disease.
Pharmabiz7h
New research highlights the role of aspirin and advanced ultrasound techniques in cardiovascular health
New research highlights the role of aspirin and advanced ultrasound techniques in cardiovascular health: Basel, Switzerland Wednesday, February 19, 2025, 11:00 Hrs [IST] With the ...
What It's Really Like Living With Heart Disease
This February, Morris-Simon and her colleagues at Bayer are leveraging Heart Month and Black History Month as an opportunity ...
Bayer® Aspirin Continues Longstanding Commitment to Heart Health Education, Encouraging Americans to "See Their Risks"
In the United States alone, 104 million people are at risk of cardiovascular disease, and in a study of those that ...
EuropaWire22h
Bayer Supports Personalized Cardiovascular Risk Assessment with New Research on Aspirin and Ultrasound Tools
Recent studies suggest that current cardiovascular risk assessment methods may be inadequate and call for a more personalized approach. Tools lik ...